Description
INTERIM AGREEMENT UNDER FSS SCHEDULE 65 I B DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS
Modification chain · 1 transaction
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2026-09-23+$0= $0
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2026-09-23 | +$0 | $0 | INTERIM AGREEMENT UNDER FSS SCHEDULE 65 I B DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI JUBZMHK84S36)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C24526N0794 | 245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS | $15,867 | FY2026 |
| 36C24526N0779 | 245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS | $33,372 | FY2026 |
| 36C24526N0725 | 245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS | $15,867 | FY2026 |
| 36C24526N0675 | 245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS | $15,867 | FY2026 |
| 36C24526N0571 | 245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS | $33,372 | FY2026 |
| 36C24526N0554 | 245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS | $17,667 | FY2026 |
Other recipients under 6505 from NAC FEDERAL SUPPLY SCHEDULE (36F797) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36F79726D0208 | WILSHIRE PHARMACEUTICALS, INC | NAC FEDERAL SUPPLY SCHEDULE (36F797) | $0 | FY2026 |
| 36F79726D0212 | 60 DEGREES PHARMACEUTICALS, INC. | NAC FEDERAL SUPPLY SCHEDULE (36F797) | $0 | FY2026 |
| 36F79726D0210 | GENZYME CORPORATION | NAC FEDERAL SUPPLY SCHEDULE (36F797) | $0 | FY2026 |
| 36F79726D0202 | CYTOKINETICS, INCORPORATED | NAC FEDERAL SUPPLY SCHEDULE (36F797) | $0 | FY2026 |
| 36F79726D0204 | LANTHEUS MEDICAL IMAGING, INC. | NAC FEDERAL SUPPLY SCHEDULE (36F797) | $0 | FY2026 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_IDV_36F79726D066E_3600 · retrieved 2026-09-27.